The skin - our protective organ - is prone to damage, which for instance can result from sheer sunlight, cellular or mechanical injury. Skin repair and skin cancer are two situations that have a lot in common,
with one important difference: repair maintains healthy, while cancer may be traumatic. Dr Michalik’s research focuses on comparing these two situations, so as to understand how skin normally repairs itself, and what goes wrong in the case of cancer. Why is such an approach used? Because comparing normal skin repair and detrimental skin cancers will help to develop clinical applications aimed at better controlling cancer progression. |
Dr. Liliane Michalik received her PhD from the University Louis Pasteur of Strasbourg in 1993, for work on microtubule-associated proteins in the group of Jean-François Launay, INSERM. In 1994, she joined the group of Walter Wahli at UNIL for her post-doctoral training, during which she initiated a research project aimed at elucidating the roles of the nuclear hormone receptors PPARs in skin homeostasis and repair.
Dr Michalik’s research focuses on understanding how skin normally repairs itself, and what goes wrong in the case of cancer. Comparing normal skin repair and detrimental skin cancers will help to develop clinical applications aimed at better controlling cancer progression. |